STOCK TITAN

Alger Associates Discloses 2,358,940-Share Position in CryoPort (CYRX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Alger Associates, Inc. filed an amendment to Schedule 13G reporting beneficial ownership of 2,358,940 shares of CryoPort, Inc. common stock, representing 4.7% of the outstanding class. The filing states Alger Associates has sole voting and sole dispositive power over these shares and that the securities are held in the ordinary course of business, not for the purpose of changing or influencing control. The filing identifies Fred Alger Management, LLC and Alger Group Holdings as related entities that manage accounts holding the securities.

Positive

  • Transparent disclosure of beneficial ownership and related-affiliate structure
  • Sole voting and dispositive power over 2,358,940 shares provides clear voting accountability

Negative

  • Stake is below 5%, limiting likelihood of material influence on corporate control

Insights

TL;DR: Disclosure shows a 4.7% stake with full voting and dispositive authority, indicating a meaningful passive position below the 5% reporting concern.

Alger Associates reports ownership of 2,358,940 shares and affirms ordinary-course holdings rather than an activist intent. The sole voting and dispositive power means the firm can make voting decisions, but at 4.7% the stake remains below the 5% mark that often triggers additional investor scrutiny or strategic expectations. This appears to be a portfolio position managed via affiliated investment vehicles.

TL;DR: The filing documents control over votes for a sub-5% position, so governance impact is limited but vote aggregation could matter in close matters.

While Alger Associates asserts sole voting power over 2,358,940 shares, the sub-5% ownership level constrains material influence on corporate control. The certification that holdings are not intended to change control reduces concerns about an imminent proxy campaign. Related-entity disclosures clarify fund and adviser structure, improving transparency for governance assessments.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein are beneficially owned by one or more open-end investment companies or other managed accounts that are investment management clients of Fred Alger Management, LLC ("FAM"), a registered investment adviser. FAM is a 100% owned subsidiary of Alger Group Holdings, LLC ("AGH"), a holding company. AGH is a 100% owned subsidiary of Alger Associates, Inc., a holding company.


SCHEDULE 13G



Alger Associates, Inc.
Signature:/s/ Hal Liebes
Name/Title:Hal Liebes / Secretary
Date:08/14/2025

FAQ

How many CryoPort (CYRX) shares does Alger Associates report owning?

Alger Associates reports beneficial ownership of 2,358,940 shares.

What percentage of CYRX does this ownership represent?

The filing states the position represents 4.7% of the class.

Does Alger Associates have voting control over these shares?

Yes, the filer reports sole voting power and sole dispositive power over the 2,358,940 shares.

Is this filing indicating an attempt to take control of CryoPort?

No; the certification states the securities are held in the ordinary course of business and not acquired to change or influence control.